Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material Threat Medical Countermeasure priority review voucher by the FDA.
Recent Posts
- Empowering EMS with PEPID’s EMS Suite: A Leap Towards Safer and More Efficient Patient Care
- The Doctor is In: A Guide to Clinical Decision Support Apps
- Surviving the Storm: The Role of Disaster Preparedness in Emergency Medicine
- Beyond Bedside Manner: Creative Solutions for Dealing with Unique Patient Challenges in the Emergency Department
- PEPID’s Impactful Collaboration with OKB Hope Foundation: Elevating Rural Healthcare